# GLP-1 Analogue Effects on Food Cues, Stress, Motivation for Highly Palatable Foods, and Weight

> **NCT04779697** · PHASE1 · COMPLETED · sponsor: **Yale University** · enrollment: 96 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** GLP-1 analogue - semaglutide
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04779697
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-01
- **Primary completion:** 2024-11-19
- **Final completion:** 2024-11-19
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2026-02-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04779697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04779697, "GLP-1 Analogue Effects on Food Cues, Stress, Motivation for Highly Palatable Foods, and Weight". Retrieved via AI Analytics 2026-05-19 from https://api.ai-analytics.org/clinical/NCT04779697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*